The M&A Advisor awarded Elliott Greenleaf the 13th annual Turnaround Award for health care/life sciences deal of the year under $500 million.

Elliott Greenleaf received the award for having served as co-counsel to the committee of unsecured creditors in Orexigen Therapeutics Inc., according to a press release from the firm.

The award is set to be presented at a gala as part of the 2019 Distressed Investing Summit, scheduled for March 27 and 28.

The gala itself is scheduled for March 28 in The Colony Hotel in Palm Beach, Florida.